AIM ImmunoTech Inc. AIM
Set alert
0.16 USD +0.01 +4.01%
At close
0.16 0.00 0.00%
Pre-market · Nov 3, 5:23 AM ET
0.1576 Day range 0.1678
0.15 52-week range 2.04
- YTD
- -85.39%
- 1 year
- -91.76%
- Open
- 0.16
- Prev close
- 0.1545
- Mkt cap
- 6.41M
- Vol
- 316.74K
- Avg vol
- 4.65M
- EPS
- -2.98
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1576
- High
- 0.1678
- Forward P/E
- -0.48
- Beta
- -0.36
- Short ratio
- 1.63
- Inst. own
- 14.07%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.232
- 200-d avg
- 0.338
- 1y target
- 2.75
5Y chart
Events in this range
- Aug 15, 2023Earnings: -0.1; estimate 0; surprise —%
- Nov 14, 2023Earnings: -0.16; estimate 0; surprise —%
- Mar 29, 2024Earnings: -0.26; estimate 0; surprise —%
- May 16, 2024Earnings: -0.12; estimate 0; surprise —%
- Aug 14, 2024Earnings: -0.03; estimate 0; surprise —%
- Sep 3, 2024Rating: Ascendiant Capital · Buy → Buy
- Oct 22, 2024Rating: Maxim Group · Buy → Buy
- Nov 14, 2024Earnings: -0.06; estimate -0.1; surprise 40%
- Dec 10, 2024Rating: Ascendiant Capital · Buy → Buy
- Jan 9, 2026Split: 1001 for 1000
Signals (87)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Jun 8, 2026 | 4 months ago |
| SMA: Bullish | Jun 1, 2026 | 5 months ago |
| RSI: Oversold | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Feb 16, 2026 | 8 months ago |
| RSI: Oversold | Feb 16, 2026 | 8 months ago |
| SMA: Bullish | Feb 9, 2026 | 8 months ago |
| RSI: Oversold | Jan 19, 2026 | 9 months ago |
| RSI: Oversold | Nov 3, 2025 | 1 year ago |
| SMA: Bearish | Oct 27, 2025 | 1 year ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| SMA: Bearish | Oct 6, 2025 | 1 year ago |
| SMA: Bullish | Sep 29, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 8, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 18, 2025 | 1 year ago |
| RSI: Oversold | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jun 16, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 26, 2025 | 1 year ago |
Newest 20 of 87.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 2.75 +1611.3% upside
Now 0.1607
- Target (low)
- 1.00
- Target (mean)
- 2.75
- Target (high)
- 4.50
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
- 2 months ago 3
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.09 | -0.09 – -0.09 | -0.2822 | +68.1% | 100.00K | +53.8% | 1 |
| Next quarter | -0.09 | -0.09 – -0.09 | -0.12 | +25.0% | 0 | -100.0% | 1 |
| Current year | -0.30 | -0.30 – -0.30 | -0.6349 | +52.8% | 200.00K | -1.0% | 1 |
| Next year | -0.37 | -0.39 – -0.35 | -0.30 | -23.3% | 2.60M | +1200.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 10, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Oct 22, 2024 | Maxim Group | Maintained | Buy | Buy |
| Sep 3, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Oct 10, 2019 | Maxim Group | Upgrade | Hold | Buy |